Blood markers may outshine standard scores in sepsis prediction
NCT ID NCT07464054
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will enroll 61 adults with sepsis in the ICU to see if certain blood-based inflammatory and nutritional markers (like NLR, PLR, PNI, and SII) can predict death and disease severity more accurately than established clinical scores like SOFA and APACHE. Researchers will compare levels of these markers between patients who survive and those who do not. The goal is to find a simpler, faster way to identify high-risk sepsis patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors use simple blood tests to quickly predict which sepsis patients are at highest risk, potentially improving early treatment decisions.
- What could go wrong
- This is a small, early-stage observational study (61 people) that only looks at existing data. It won't test a new treatment, and results may not apply to all sepsis patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMATORY MARKERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?